Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Seminars and events

At the Nuffield Department of Women's & Reproductive Health (NDWRH) and the National Perinatal Epidemiology Unit (NPEU)

Alongside a wider programme of seminars, courses and events delivered throughout the year, we run regular Departmental Seminars during term time on Tuesdays in the Anne Anderson Lecture Theatre. These sessions provide an opportunity to hear from both internal and external speakers on topics aligned with our research themes, and offer updates on research, methods and skills.

Our broader events programme takes place across a range of times and locations. While some sessions are designed specifically for internal colleagues, most are open to external attendees, including members of the public and healthcare professionals. Together, these activities support learning, collaboration and networking across NDWRH, NPEU and the wider community.

Dr Mike Suttie manages our department seminars. If you would like to recommend a speaker, or have any questions, please get in touch at seminars@wrh.ox.ac.uk

Useful links

Latest news

Oxford to lead Europe's largest miscarriage research centre in partnership with Tommy's

The Nuffield Department of Women's & Reproductive Health is proud to announce that it is now leading Tommy's National Centre for Miscarriage Research, alongside existing partners: the University of Birmingham, the University of Warwick, and Imperial College London.

Ovarian Cancer Awareness Day 2026 highlights the need for earlier detection and better outcomes

Today, on World Ovarian Cancer Day, we recognise the impact ovarian cancer has on women and families worldwide, and the urgent need for earlier diagnosis, improved treatment, and better survival outcomes. The day also highlights the importance of continued research to improve understanding of ovarian cancer biology, diagnosis, treatment, and patient outcomes. High-grade serous ovarian cancer is the most common subtype of ovarian cancer, with many patients diagnosed at an advanced stage. Survival outcomes remain closely linked to the stage at which the disease is diagnosed.

Phase 2 Endometriosis Study Highlights a Novel Molecular Imaging Agent as a Promising Diagnostic and Monitoring Tool

A Phase II Study, published in The Lancet Obstetrics, Gynaecology & Women's Health, highlights the potential of a new molecular imaging agent, ‘99mTc-maraciclatide’, when used alongside a non-invasive scan to diagnose and monitor the development and treatment of Endometriosis.

New model of care could prevent more than 10,000 miscarriages a year in the UK, Tommy’s report suggests

Publications

Post-catalysis structures of mitochondrial complex I with ubiquinol-10 bound in the active site

Journal article

Chung I. et al, (2026), Nature Communications, 17

FINE-EM-seq: a rapid isothermal amplification method enabling comprehensive methylome profiling of zebrafish early embryos

Journal article

Ding C. et al, (2026), Cell Insight, 5, 100324 - 100324

Development of the INDIGO partnership knowledge exchange strategy

Journal article

Taylor Salisbury T. et al, (2026), SSM - Mental Health, 9, 100602 - 100602

AI-assisted placenta pathology in clinical use: barriers and opportunities.

Journal article

Walker EC. et al, (2026), Placenta